<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:tpst="http://www.tempesttx.com/20241007"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tpst-20241007.xsd" xlink:type="simple"/>
    <context id="duration_2024-10-07_to_2024-10-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
        </entity>
        <period>
            <startDate>2024-10-07</startDate>
            <endDate>2024-10-07</endDate>
        </period>
    </context>
    <context id="duration_2024-10-07_to_2024-10-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-07</startDate>
            <endDate>2024-10-07</endDate>
        </period>
    </context>
    <context id="duration_2024-10-07_to_2024-10-07_us-gaap-StatementClassOfStockAxis_tpst-SeriesAJuniorParticipatingPreferredPurchaseRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tpst:SeriesAJuniorParticipatingPreferredPurchaseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-07</startDate>
            <endDate>2024-10-07</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-10-07_to_2024-10-07"
      id="Hidden_dei_EntityCentralIndexKey_duration_2024-10-07_to_2024-10-07">0001544227</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2024-10-07_to_2024-10-07"
      id="Hidden_dei_AmendmentFlag_duration_2024-10-07_to_2024-10-07">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_0">2024-10-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_16">TEMPEST THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_4">001-35890</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_5">45-1472564</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_6">2000 Sierra Point Parkway, Suite 400</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_7">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_8">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_9">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_10">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_11">798-8589</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_20">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_22">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2024-10-07_to_2024-10-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="Fact_23">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-10-07_to_2024-10-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="Fact_24">TPST</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-10-07_to_2024-10-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="Fact_25">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-10-07_to_2024-10-07_us-gaap-StatementClassOfStockAxis_tpst-SeriesAJuniorParticipatingPreferredPurchaseRightsMember"
      id="Fact_26">Series A Junior Participating Preferred Purchase Rights</dei:Security12bTitle>
    <dei:NoTradingSymbolFlag
      contextRef="duration_2024-10-07_to_2024-10-07_us-gaap-StatementClassOfStockAxis_tpst-SeriesAJuniorParticipatingPreferredPurchaseRightsMember"
      id="Fact_27">true</dei:NoTradingSymbolFlag>
    <dei:SecurityExchangeName
      contextRef="duration_2024-10-07_to_2024-10-07_us-gaap-StatementClassOfStockAxis_tpst-SeriesAJuniorParticipatingPreferredPurchaseRightsMember"
      id="Fact_28">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-10-07_to_2024-10-07" id="Fact_15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
